Breastfeeding Rates and the Relationship Between Breastfeeding and Neonatal Abstinence Syndrome in Women Maintained on Buprenorphine During Pregnancy
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Introduction: Although a growing body of evidence suggests that buprenorphine is a safe alternative to methadone in the treatment of opioid‐dependent pregnant women, little is known about breastfeeding in this population. The first objective of this study was to describe breastfeeding rates among opioid‐dependent pregnant women maintained on buprenorphine in an integrated medical and behavioral health program. The second objective was to determine whether breastfeeding is related to the duration, severity, and frequency of pharmacologic treatment for neonatal abstinence syndrome (NAS). Methods: A retrospective chart review was conducted for all infants born to opioid‐dependent pregnant women treated in the integrated buprenorphine program between December 2007 and August 2012. Results: Eighty‐five maternal‐infant pairs were identified. Sixty‐five women (76%) chose to breastfeed their infants after birth; of the women who initiated breastfeeding in the hospital, 66% were still breastfeeding 6 to 8 weeks postpartum. Although the data suggest that infants who were breastfed had less severe NAS (mean peak NAS, 8.83 vs 9.65 on a modified Finnegan Scoring System) and were less likely to require pharmacologic treatment (23.1% vs 30.0%) than infants who were not breastfed, these results were not statistically significant. Discussion: More than three‐quarters of the opioid‐dependent pregnant women in this case series chose to breastfeed after birth. Although a direct comparison of care models is not possible, the integrated model of care potentially reduced some of the barriers to breastfeeding as the women accessed all their care in a single, infant‐friendly setting. Further work is needed to definitively determine whether breastfeeding mitigates NAS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Transfer of Drugs and Other Chemicals Into Human Milk
Committee on Drugs (2001) · Pediatrics · doi:10.1542/peds.108.3.776 · Cited by 1,256
Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005359 · Cited by 986
Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes
Johnson, R. E., Jones, H. E., Jasinski, D. R., Svikis, D. S., Haug, N. A., Jansson, L. M., Kissin, W. B., Alpan, G., Lantz, M. E., Cone, E. J., et al. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00194-0 · Cited by 125
Cited by
Kocherlakota, P. (2014) · Pediatrics · doi:10.1542/peds.2013-3524 · Cited by 612
Substance use during pregnancy
Forray, A. (2016) · F1000Research · doi:10.12688/f1000research.7645.1 · Cited by 311
Technical Report: Breastfeeding and the Use of Human Milk
Meek, J. Y., & Noble, L. (2022) · Pediatrics · doi:10.1542/peds.2022-057989 · Cited by 176
Prenatal and Postpartum Care of Women with Substance Use Disorders
Gopman, S. (2014) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2014.02.004 · Cited by 88
Convertino, I., Sansone, A. C., Marino, A., Galiulo, M. T., Mantarro, S., Antonioli, L., Fornai, M., Blandizzi, C., & Tuccori, M. (2016) · Drug Safety · doi:10.1007/s40264-016-0435-8 · Cited by 32
Corsi, D. J., & Murphy, M. S. Q. (2021) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13577 · Cited by 17
Metadata
- Authors
- O'Connor, A. B., Collett, A., Alto, W. A., & O'Brien, L. M.
- Venue
- Journal of Midwifery & Women's Health
- Publisher
- Wiley
- Published
- 2013-07
- Volume
- 58
- Issue
- 4
- Pages
- 383-388
- ISSN
- 1526-9523 (ISSN-L)
- 1542-2011
- OpenAlex
- W2060552913
- Cited by
- 73
- References
- 3
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.